Correlation Between Bio Path and Artelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Bio Path and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Path Holdings and Artelo Biosciences, you can compare the effects of market volatilities on Bio Path and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Artelo Biosciences.

Diversification Opportunities for Bio Path and Artelo Biosciences

0.51

Correlation Coefficient

Bio Path  Artelo Biosciences

Very weak diversification

The 3 months correlation between Bio and Artelo is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Bio Path i.e., Bio Path and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Bio Path and Artelo Biosciences

Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Artelo Biosciences. In addition to that, Bio Path is 3.99 times more volatile than Artelo Biosciences. It trades about -0.19 of its total potential returns per unit of risk. Artelo Biosciences is currently generating about -0.02 per unit of volatility. If you would invest  106.00  in Artelo Biosciences on December 27, 2024 and sell it today you would lose (9.00) from holding Artelo Biosciences or give up 8.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	63.33%
Values	Daily Returns

Bio Path Holdings  vs.  Artelo Biosciences

Bio Path Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Artelo Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Bio Path and Artelo Biosciences

The main advantage of trading using opposite Bio Path and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.

The idea behind Bio Path Holdings and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.